Opicapone API

Name	Opicapone
Chinese name	奥匹卡朋
Cas Number	923287-50-7
Source	Spain
Qualifications	-/-/-/-

 

A Novel Selective Catechol Oxymethyltransferase (COMT) Inhibitor Prolongs the Clinical Efficacy of Levodopa and Ameliorates Fading by Decreasing the Conversion Rate of Levodopa to 3-O-Methyldopa phenomenon, can increase the bioavailability of levodopa by 65%. European, American, and China treatment guidelines clearly recommend COMT inhibitors as first-line drugs to assist dopamine in the treatment of patients with Parkinson's disease, which can effectively reduce the "OFF" period of patients with Parkinson's disease. Adherence to treatment. The population of patients is large, and Parkinson's disease patients are gradually becoming younger. Juvenile Parkinson's disease patients account for 10% of the total number of patients. At present, the total number of patients in China has more than 2 million, accounting for about 50% of the world, that is, more than half of the world's Parkinson's disease patients with Kinsen's disease live in China. The capsule dosage form (25mg, 50mg) of this product is a reference variety. At present, the original research is in the third phase of clinical recruitment in China, and our company can be the general agent of foreign raw materials.

 

For more information please feel free to get in touch with us today!

Email: tonghuiyy218@upharm.cn

Wechat/Whatsapp:+86-189-2212-0635

Hot Tags: opicapone api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Paliperidone API, Clofarabine API, Gabapentin API, Tippyridine Hydrochloride API, Dapoxetine API, Pleasant API

• Previous: Mianserin Hydrochloride API
• Next: Labetalol HCL API